These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 18090180)

  • 1. Cardiovascular risk factors and metabolic syndrome in alcohol- and nicotine-dependent men and women.
    Jarvis CM; Hayman LL; Braun LT; Schwertz DW; Ferrans CE; Piano MR
    J Cardiovasc Nurs; 2007; 22(6):429-35. PubMed ID: 18090180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between prehypertension and clustering of cardiovascular disease risk factors among Chinese adults.
    Yu D; Huang J; Hu D; Chen J; Cao J; Li J; Gu D
    J Cardiovasc Pharmacol; 2009 May; 53(5):388-400. PubMed ID: 19454899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects.
    Vidal J; Morínigo R; Codoceo VH; Casamitjana R; Pellitero S; Gomis R
    Int J Obes (Lond); 2005 Jun; 29(6):668-74. PubMed ID: 15753955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
    Muntner P; He J; Chen J; Fonseca V; Whelton PK
    Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990-2000.
    Kadota A; Hozawa A; Okamura T; Kadowak T; Nakmaura K; Murakami Y; Hayakawa T; Kita Y; Okayama A; Nakamura Y; Kashiwagi A; Ueshima H;
    Diabetes Care; 2007 Jun; 30(6):1533-8. PubMed ID: 17363755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the metabolic syndrome as influenced by the measure of obesity employed.
    Vega GL; Barlow CE; Grundy SM
    Am J Cardiol; 2010 May; 105(9):1306-12. PubMed ID: 20403484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
    DECODE Study Group
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factor prevalence among men in a large industry of northern India.
    Prabhakaran D; Shah P; Chaturvedi V; Ramakrishnan L; Manhapra A; Reddy KS
    Natl Med J India; 2005; 18(2):59-65. PubMed ID: 15981439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study.
    Onat A; Hergenç G; Sari I; Türkmen S; Can G; Sansoy V
    Am J Hypertens; 2005 Mar; 18(3):409-16. PubMed ID: 15797662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome.
    Onat A; Hergenç G; Keleş I; Doğan Y; Türkmen S; Sansoy V
    Metabolism; 2005 Jun; 54(6):800-8. PubMed ID: 15931618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revised Adult Treatment Panel III guidelines and cardiovascular disease mortality in men attending a preventive medical clinic.
    Ardern CI; Katzmarzyk PT; Janssen I; Church TS; Blair SN
    Circulation; 2005 Sep; 112(10):1478-85. PubMed ID: 16129792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality.
    Tsai SP; Wen CP; Chan HT; Chiang PH; Tsai MK; Cheng TY
    Diabetes Res Clin Pract; 2008 Oct; 82(1):148-56. PubMed ID: 18757109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An epidemiological study on cardiovascular risk factors in 35-64 years old Spanish population].
    Banegas Banegas JR; Villar Alvarez F; Pérez de Andrés C; Jiménez García-Pascual R; Gil López E; Muñiz García J; Juane Sánchez R
    Rev Sanid Hig Publica (Madr); 1993; 67(6):419-45. PubMed ID: 7732310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMI versus the metabolic syndrome in relation to cardiovascular risk in elderly Chinese individuals.
    He Y; Jiang B; Wang J; Feng K; Chang Q; Zhu S; Fan L; Li X; Hu FB
    Diabetes Care; 2007 Aug; 30(8):2128-34. PubMed ID: 17468350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.